Intrinsic Value of S&P & Nasdaq Contact Us

Atreca, Inc. BCEL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
38/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.00
+4344.4%

Atreca, Inc. (BCEL) has a consensus analyst rating of Buy, based on 8 analysts covering the stock. Of those, 4 recommend buying, 4 recommend holding, and 0 recommend selling.

The analyst consensus price target for BCEL is $4.00, representing a +4,344.4% upside from the current price of $0.09. Price targets range from a low of $4.00 to a high of $4.00.

Analyst Consensus — BCEL

Buy
Strong Buy
0
Buy
4
Hold
4
Sell
0
Strong Sell
0
8 analysts
Price Targets
Consensus$4.00
High$4.00
Low$4.00
Median$4.00
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message